10-Q: Venus Concept Q3 2025: Losses Widen, Hair Business Sale in Court

Venus Concept Inc. reported a significantly increased net loss and revenue decline for Q3 2025, exacerbated by geopolitical conflicts and substantial debt extinguishment losses, while its Venus Hair Business sale faces legal challenges.

Summary

• Net loss for the three months ended September 30, 2025, significantly increased to $22.5 million from $9.3 million in the prior year period.
• Total revenue decreased by 8.2% to $13.8 million in Q3 2025 and by 12.1% to $43.1 million for the nine months ended September 30, 2025, compared to the prior year periods.
• Gross profit decreased by 11.1% in Q3 2025 to $8.8 million, with gross margin falling to 64.0% from 66.1% in Q3 2024.
• Operating expenses for Q3 2025 rose by 7.2% to $18.3 million, primarily due to higher selling and marketing and general and administrative costs.
• A substantial non-cash loss on debt extinguishment of $11.3 million was recognized in Q3 2025, contributing significantly to the increased net loss.
• The company continues to face substantial doubt about its ability to continue as a going concern due to recurring net operating losses and negative cash flows from operations.
• A Unit Purchase Agreement to sell the Venus Hair Business for $20 million is pending, with the company filing a complaint in the Delaware Court of Chancery on November 7, 2025, to assist in closing the transaction.
• Cash used in operating activities for the nine months ended September 30, 2025, increased to $16.6 million from $7.3 million in the prior year period.
• Total debt obligations decreased to $30.1 million as of September 30, 2025, from $39.7 million as of December 31, 2024, primarily through debt-to-equity exchanges.
• The company regained compliance with Nasdaq's minimum stockholder equity and bid price requirements during the reporting period.

Sentiment

Score: 2

Explanation: The company faces severe financial distress with widening net losses, declining revenues, and significant cash burn. The 'going concern' warning, geopolitical risks, and legal challenges to a key asset sale indicate a highly negative outlook despite some debt reduction and Nasdaq compliance.

Positives

• Regained compliance with Nasdaq's minimum stockholder equity requirement by June 4, 2024.
• Regained compliance with Nasdaq's minimum bid price requirement by March 18, 2025, following a 1-for-11 reverse stock split.
• Total debt obligations decreased to $30.1 million as of September 30, 2025, from $39.7 million as of December 31, 2024.
• Research and development expenses decreased by 24.3% in Q3 2025 and 19.6% for the nine months ended September 30, 2025, due to consolidation of activities.
• Foreign exchange resulted in a $0.7 million gain for the nine months ended September 30, 2025, a favorable variance of $1.9 million year-over-year.
• Allowance for expected credit losses decreased by 45% to $2.1 million as of September 30, 2025, from $3.8 million as of December 31, 2024.

Negatives

• Net loss for the three months ended September 30, 2025, significantly increased to $22.5 million from $9.3 million in the prior year period.
• Net loss for the nine months ended September 30, 2025, increased to $46.7 million from $39.0 million in the prior year period.
• Total revenue decreased by 8.2% to $13.8 million in Q3 2025 and by 12.1% to $43.1 million for the nine months ended September 30, 2025, compared to the prior year periods.
• Gross profit decreased by 11.1% in Q3 2025 and 19.2% for the nine months ended September 30, 2025, with gross margin declining to 64.0% and 62.6% respectively.
• Operating expenses increased by 7.2% in Q3 2025 and 2.1% for the nine months ended September 30, 2025.
• Adjusted EBITDA loss widened to $7.8 million in Q3 2025 and $25.0 million for the nine months ended September 30, 2025.
• Cash used in operating activities for the nine months ended September 30, 2025, increased by $9.4 million to $16.6 million.
• Accumulated deficit increased to $355.5 million as of September 30, 2025, from $308.9 million as of December 31, 2024.
• A substantial non-cash loss on debt extinguishment of $11.3 million was recognized in Q3 2025, contributing to the increased net loss.
• Systems delivered decreased to 198 in Q3 2025 from 253 in Q3 2024, and to 630 for the nine months ended September 30, 2025, from 789 in the prior year.
• The company has recurring net operating losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern.

Risks

• Dependency on internal lease programs exposes the company to customer credit risk and potential payment defaults.
• Customers' ability to secure third-party financing is impacted by tightened credit markets and higher interest rates.
• Extensive governmental regulation and oversight in operating countries, requiring continuous compliance.
• Potential for systems to cause or contribute to adverse medical events, harming reputation and financial results.
• Significant portion of operations in Israel, making the business vulnerable to political, economic, and military conditions, including the Israel-Hamas and Israel-Iran conflicts, which have caused supply disruptions.
• Volatility of the company's stock price.
• Dependency on one major contract manufacturer in Israel exposes the company to supply disruptions from strikes, shutdowns, or natural disasters.
• Reliance on the expertise and retention of management.
• Ability to access capital markets and/or obtain credit on favorable terms is uncertain.
• Inflation, currency fluctuations, and currency exchange rates negatively impact costs and margins.
• Global supply disruptions, particularly from geopolitical events in the Middle East, affecting production lead times and ability to meet demand.
• Global economic and political conditions and uncertainties, including potential recessionary impacts.
• Increased U.S. tariffs on goods imported from Israel (15%) will increase cost of goods and cause margin erosion.
• The pending sale of the Venus Hair Business is subject to numerous closing conditions, and there is no assurance it will be completed on anticipated terms or at all, with litigation initiated to assist in closing.

Future Outlook

The global economy, including financial and credit markets, continues to experience extreme volatility due to persistent inflation, high interest rates, and geopolitical instability. The company anticipates continued supply chain challenges for the remainder of 2025, particularly due to Middle East geopolitical disruptions impacting shipping and production lead times, which may affect its ability to meet customer demand. Increased U.S. tariffs on Israeli imports are expected to raise cost of goods and modestly erode margins. While central banks have begun reducing interest rates, the severity and duration of these conditions on the business remain unpredictable. The company will continue to adapt to macro-economic challenges and leverage opportunities from easing monetary policy.

Management Comments

• We have had recurring net operating losses and negative cash flows from operations. Until we generate revenue at a level to support our cost structure, we expect to continue to incur substantial operating losses and negative cash flows from operations.
• In order to continue our operations, we must achieve profitability and/or obtain additional equity investment or debt financing.
• We remain focused on adapting to the challenges presented by the current macro-economic environment, as well as the opportunities presented by an easing of monetary policy.
• We remain steadfast in ensuring that our in-house financing program accepts only qualified customers with the goal to reduce future credit losses, often at the expense of topline revenue.

Industry Context

The medical aesthetic and hair restoration industry is currently navigating a challenging global economic environment characterized by persistent inflation, high interest rates, and geopolitical instability. These factors are tightening credit markets, making it harder for customers to secure financing for capital equipment, and impacting consumer confidence. While some central banks have begun to ease monetary policy by reducing interest rates, the industry faces ongoing supply chain disruptions, particularly for companies with manufacturing ties to regions affected by conflicts like Israel. Increased tariffs also add to cost pressures, potentially eroding margins across the sector. Companies are adapting by focusing on cash sales and stricter credit screening, while also pursuing strategic alternatives to maximize shareholder value.

Legal Proceedings

• Filed a complaint with the Delaware Court of Chancery on November 7, 2025, seeking assistance to close the Unit Purchase Agreement for the Venus Hair Business.
• No other material active or pending legal proceedings as of September 30, 2025.

Stakeholder Impact

• Shareholders: Significant dilution from debt-to-equity conversions and direct offerings, increased accumulated deficit, ongoing stock price volatility, and potential adverse outcomes from the Venus Hair Business sale litigation.
• Employees: Potential impact on job security due to cost-cutting measures and the sale of the Venus Hair Business, as well as direct and indirect effects from geopolitical conflicts in Israel.
• Customers: Challenges in securing third-party financing due to tightened credit markets and higher interest rates, potential product availability issues due to supply chain disruptions.
• Creditors/Lenders: Ongoing negotiations and amendments to debt agreements, including maturity extensions and waivers of covenants, indicating continued financial risk.
• Suppliers: Supply chain disruptions, particularly for those in Israel, affecting production and delivery schedules.

Next Steps

• Continue evaluating strategic alternatives to maximize shareholder value.
• Pursue the closing of the Venus Hair Business sale, including through litigation in the Delaware Court of Chancery.
• Focus on adapting to macro-economic challenges and leveraging opportunities from easing monetary policy.
• Continue efforts to mitigate supply chain issues and build inventory of key component parts.
• Maintain focus on revised credit screening practices to reduce bad debt expenses.
• Introduce and commercialize new products and grow sales and marketing force.
• Implement new software systems and identify and penetrate new markets.

Key Dates

Recommendation

The company is in severe financial distress, evidenced by widening net losses, declining revenues, and a substantial increase in cash used in operations. The 'going concern' warning is a critical red flag. While debt has been reduced through exchanges, this comes at the cost of significant dilution. Geopolitical risks in Israel continue to impact operations and supply chains, and the crucial sale of the Venus Hair Business is now subject to litigation, adding further uncertainty. Despite regaining Nasdaq compliance, the fundamental business performance and outlook are highly negative, suggesting a strong sell recommendation for investors.

Keywords

Venus Concept, VERO, Q3 2025 Earnings, Medical Technology, Aesthetic Devices, Hair Restoration, SEC Filing, 10-Q, Financial Results, Debt Restructuring, Nasdaq Compliance, Geopolitical Risk, Supply Chain, Capital Raise, Going Concern, Venus Hair Business Sale, ARTAS, NeoGraft, AI.ME